Your Health, We Care
Release date: 2026-02-05 17:09:29 Article From: Lucius Laos Recommended: 5
Some medications are absolutely contraindicated for combined use. For other medications, even if drug interactions may occur, they can still be used under the guidance of a physician. In such cases, the doctor may adjust the dosage or take other necessary preventive measures.
During treatment with this medication, you must inform your healthcare providers of all the following drugs you are taking (the interactions listed are screened based on potential clinical significance and do not cover all possibilities):
Not recommended for combined use: The doctor may discontinue Cabozantinib or adjust other medications you are taking.
Bacillus Calmette-Guérin (BCG) vaccine (live attenuated vaccine).
Quadrivalent dengue live attenuated vaccine.
Measles live attenuated vaccine.
Mumps live attenuated vaccine.
Rubella live attenuated vaccine.
Smallpox/monkeypox vaccine.
Typhoid vaccine.
Varicella live attenuated vaccine.
Yellow fever vaccine.
Other medical conditions may affect the use of this medication. Be sure to inform your doctor of all your other health conditions, especially the following:
Hemorrhagic disorders, thrombotic diseases, acute myocardial infarction, heart disease, uncontrolled hypertension, hypocalcemia, hypothyroidism, proteinuria, gastric fistula/perforation, recent stroke: Use with caution; these conditions may be exacerbated.
Dental problems, dental procedures/surgery, poor oral hygiene, dental infections: May increase the risk of severe jaw disorders.
Recent hematemesis, hemoptysis, history of severe bleeding, melena: Contraindicated.
Mild to moderate liver disease: Use with caution; delayed drug clearance may enhance the drug’s efficacy.
Severe liver disease: Contraindicated.
Store in a sealed container at room temperature, away from heat sources, moisture, direct sunlight, and do not freeze.
Keep out of reach of children.
Do not retain expired or unused medications. Consult your healthcare provider for proper disposal methods.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：832025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：3752024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：742025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：952025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：902025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：1052025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：1032025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：1002025-27-11
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
